Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain × Morphine × Clear all

Phase

Phase 3 5 Phase 2 5 Phase NA 4 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 3 Chronic Pain 3 Cancer Pain 3 Supratentorial Neoplasms 2 Pain, Postoperative 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pain 1 Neoplasm, Residual 1 Nalbuphine Allergy 1 Ileus 1 Head and Neck Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Breakthrough Pain 1 Brain Neoplasms 1 Agnosia 1 Age Problem 1 Abdominal Cancer 1

Interventions

Fentanyl 7 Acetaminophen 5 Zoledronic Acid 4 Oxycodone 4 Bupivacaine 4 Sufentanil 3 Ketamine 3 Hydromorphone 3 Diclofenac 3 Ropivacaine 2 Pregabalin 2 Ketorolac 2 Ibuprofen 2 Ibandronic Acid 2 Esketamine 2 Epinephrine 2 naloxegol 1 chloroprocaine 1 acetaminophen, aspirin, caffeine drug combination 1 Varenicline 1 Uterine Artery Embolization 1 Ultracet 1 Therapeutics 1 Propofol 1 Pamidronate 1 Naproxen 1 Morphine 1 Methadone 1 Meperidine 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378937 2013-08-02

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

National Cancer Institute (NCI)

Phase 4 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡